| Sign In to gain access to subscriptions and/or personal tools. |
Clinical Pediatrics, Vol. 47, No. 5, 446-451 (2008) DOI: 10.1177/0009922807312184 Periodic Use of Inhaled Steroids in Children With Mild Persistent Asthma: What Are Pediatricians Recommending?Harvard Pediatric Health Services Research Fellowship Program, Children's Hospital Boston, Boston, gregory.sawicki{at}childrens.harvard.edu
Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston
Boston University School of Public Health, Boston, Center for Health Quality, Outcomes and Economic Research, ENRM Veterans Affairs Medical Center, Bedford, Massachusetts
Center for Child Health Care Studies, Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston
Center for Child Health Care Studies, Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston
Center for Child Health Care Studies, Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston
Harvard Pediatric Health Services Research Fellowship Program, Children's Hospital Boston, Boston, Center for Child Health Care Studies, Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston, Division of General Pediatrics, Children's Hospital Boston
Although asthma treatment guidelines recommend daily inhaled corticosteroid (ICS) use for all persistent asthma, pediatricians may recommend alternative treatment plans for children with mild persistent disease. The authors administered a survey of pediatricians to describe prescribing patterns for mild persistent asthma. More than 99% of providers agreed that periodic ICS could be effective for some asthma patients. Overall, 129/251 providers (51%) reported prescribing daily ICS to most patients with mild persistent asthma, whereas 78 (31%) reported recommending periodic ICS for most such patients. Providers with patient populations
Key Words: mild persistent asthma treatment guidelines inhaled corticosteroids leukotriene modifiers
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25% black were significantly less likely to report prescribing daily ICS (odds ratio, 0.3; 95% confidence interval, 0.2-0.6) for mild persistent asthma. Further research is needed on the effectiveness of periodic ICS use for children with mild persistent asthma and on underlying reasons for differing provider practice patterns.